{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T02:27:20Z","timestamp":1792981640384,"version":"4.5.0"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"National Institute of Health","award":["5-R01-HL070241"],"award-info":[{"award-number":["5-R01-HL070241"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Growth Hormone &amp; IGF Research"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.ghir.2019.01.002","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T22:16:35Z","timestamp":1548972995000},"page":"6-16","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":148,"special_numbering":"C","title":["IGF-1 and cardiovascular disease"],"prefix":"10.1016","volume":"45","author":[{"given":"Yusuke","family":"Higashi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Delafontaine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiy","family":"Sukhanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ghir.2019.01.002_bb0005","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980\u20132016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.ghir.2019.01.002_bb0010","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1161\/CIRCRESAHA.116.309512","article-title":"Why so few new cardiovascular drugs translate to the clinics","volume":"119","author":"Vatner","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0015","first-page":"II3","article-title":"Coronary atherosclerosis. A multifactorial disease","volume":"87","author":"Badimon","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0020","doi-asserted-by":"crossref","first-page":"92S","DOI":"10.1016\/S0895-7061(99)00163-6","article-title":"Coronary heart disease is a multifactorial disease","volume":"12","author":"Poulter","year":"1999","journal-title":"Am. J. Hypertens."},{"key":"10.1016\/j.ghir.2019.01.002_bb0025","first-page":"40","article-title":"Pathogenesis of atherosclerosis: a multifactorial process","volume":"7","author":"Singh","year":"2002","journal-title":"Exp. Clin. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0030","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1152\/physrev.00047.2003","article-title":"Role of oxidative modifications in atherosclerosis","volume":"84","author":"Stocker","year":"2004","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.ghir.2019.01.002_bb0035","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1161\/hc0502.104540","article-title":"Fundamentals of endothelial function for the clinical cardiologist","volume":"105","author":"Verma","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0040","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1161\/CIRCRESAHA.115.306301","article-title":"Endothelial cell dysfunction and the pathobiology of atherosclerosis","volume":"118","author":"Gimbrone","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0045","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI83083","article-title":"Endothelial fluid shear stress sensing in vascular health and disease","volume":"126","author":"Baeyens","year":"2016","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2019.01.002_bb0050","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/ars.2015.6493","article-title":"Endothelial mechanosignaling: does one sensor fit all?","volume":"25","author":"Givens","year":"2016","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.ghir.2019.01.002_bb0055","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00281-011-0285-5","article-title":"Endothelium--role in regulation of coagulation and inflammation","volume":"34","author":"van Hinsbergh","year":"2012","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0060","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.ajpath.2013.12.033","article-title":"How endothelial cells regulate transmigration of leukocytes in the inflammatory response","volume":"184","author":"Muller","year":"2014","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0065","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2013.00161","article-title":"The role of tissue Renin-Angiotensin-aldosterone system in the development of endothelial dysfunction and arterial stiffness","volume":"4","author":"Aroor","year":"2013","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2019.01.002_bb0070","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jacc.2011.11.082","article-title":"Endothelial dysfunction, arterial stiffness, and heart failure","volume":"60","author":"Marti","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0075","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1161\/CIRCRESAHA.115.306361","article-title":"Vascular smooth muscle cells in atherosclerosis","volume":"118","author":"Bennett","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0080","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nm.3866","article-title":"KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis","volume":"21","author":"Shankman","year":"2015","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0085","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1161\/CIRCRESAHA.115.304634","article-title":"Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis","volume":"115","author":"Feil","year":"2014","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nmeth.2332","article-title":"Detection of histone modifications at specific gene loci in single cells in histological sections","volume":"10","author":"Gomez","year":"2013","journal-title":"Nat. Methods"},{"key":"10.1016\/j.ghir.2019.01.002_bb0095","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nm0402-403","article-title":"Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis","volume":"8","author":"Sata","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0100","doi-asserted-by":"crossref","first-page":"4754","DOI":"10.1073\/pnas.0730743100","article-title":"Smooth muscle cells in human coronary atherosclerosis can originate from cells administered at marrow transplantation","volume":"100","author":"Caplice","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ghir.2019.01.002_bb0105","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1161\/CIRCULATIONAHA.110.965202","article-title":"Bone marrow-derived cells contribute to vascular inflammation but do not differentiate into smooth muscle cell lineages","volume":"122","author":"Iwata","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0110","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1161\/ATVBAHA.0000258865.44774.41","article-title":"Is pathologic intimal thickening the key to understanding early plaque progression in human atherosclerotic disease?","volume":"27","author":"Kolodgie","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0115","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1093\/cvr\/cvu171","article-title":"Emerging regulators of vascular smooth muscle cell function in the development and progression of atherosclerosis","volume":"103","author":"Johnson","year":"2014","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.atherosclerosis.2018.03.039","article-title":"Pathologic intimal thickening in human atherosclerosis is formed by extracellular accumulation of plasma-derived lipids and dispersion of intimal smooth muscle cells","volume":"274","author":"Nakagawa","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0125","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2018.04.033","article-title":"Pathologic intimal thickening: are we any closer to understand early transitional plaques that lead to symptomatic disease?","volume":"274","author":"Sakamoto","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0130","first-page":"825","article-title":"The nature of diffuse intimal thickening of arteries","volume":"27","author":"Wilens","year":"1951","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0135","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1161\/01.ATV.19.9.2036","article-title":"Neonatal intima formation in the human coronary artery","volume":"19","author":"Ikari","year":"1999","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0140","first-page":"1023","article-title":"The diffuse intimal thickening of the human aorta with aging","volume":"34","author":"Movat","year":"1958","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0145","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/0021-9150(85)90008-5","article-title":"Study of coronary intimal thickening","volume":"56","author":"Velican","year":"1985","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0150","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1161\/ATVBAHA.107.159327","article-title":"Role of smooth muscle cells in the initiation and early progression of atherosclerosis","volume":"28","author":"Doran","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0155","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.atherosclerosis.2015.05.011","article-title":"Natural progression of atherosclerosis from pathologic intimal thickening to late fibroatheroma in human coronary arteries: a pathology study","volume":"241","author":"Otsuka","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0160","doi-asserted-by":"crossref","first-page":"20419","DOI":"10.1016\/S0021-9258(20)80745-5","volume":"268","author":"Tabas","year":"1993","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0165","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/0735-1097(88)90356-7","article-title":"Angiographic progression of coronary artery disease and the development of myocardial infarction","volume":"12","author":"Ambrose","year":"1988","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0170","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1161\/CIRCRESAHA.115.306256","article-title":"Macrophage phenotype and function in different stages of atherosclerosis","volume":"118","author":"Tabas","year":"2016","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0175","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.tem.2009.12.005","article-title":"IGF-1, oxidative stress and atheroprotection","volume":"21","author":"Higashi","year":"2010","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0180","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1093\/gerona\/gls102","article-title":"Aging, atherosclerosis, and IGF-1","volume":"67","author":"Higashi","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ghir.2019.01.002_bb0185","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3389\/fendo.2018.00117","article-title":"IGF-binding proteins: why do they exist and why are there so many?","volume":"9","author":"Allard","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2019.01.002_bb0190","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0021-9150(86)90093-6","article-title":"Growth factors and the pathogenesis of atherosclerosis","volume":"62","author":"Nilsson","year":"1986","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0195","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/362801a0","article-title":"The pathogenesis of atherosclerosis: a perspective for the 1990s","volume":"362","author":"Ross","year":"1993","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2019.01.002_bb0200","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S0002-9440(10)62061-5","article-title":"The absence of platelet-derived growth factor-B in circulating cells promotes immune and inflammatory responses in atherosclerosis-prone ApoE\u2212\/\u2212 mice","volume":"167","author":"Tang","year":"2005","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0205","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1126\/science.2343305","article-title":"Localization of PDGF-B protein in macrophages in all phases of atherogenesis","volume":"248","author":"Ross","year":"1990","journal-title":"Science"},{"key":"10.1016\/j.ghir.2019.01.002_bb0210","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/S0002-9440(10)64415-X","article-title":"Blockade of platelet-derived growth factor or its receptors transiently delays but does not prevent fibrous cap formation in ApoE null mice","volume":"161","author":"Kozaki","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0215","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1194\/jlr.R500004-JLR200","article-title":"Thematic review series: the immune system and atherogenesis. Cytokines affecting endothelial and smooth muscle cells in vascular disease","volume":"46","author":"Raines","year":"2005","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0220","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1161\/ATVBAHA.109.186593","article-title":"TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice","volume":"29","author":"Frutkin","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0225","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1161\/ATVBAHA.107.156257","article-title":"IGF-1 reduces inflammatory responses, suppresses oxidative stress, and decreases atherosclerosis progression in ApoE-deficient mice","volume":"27","author":"Sukhanov","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0230","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1161\/CIRCULATIONAHA.116.021805","article-title":"Insulin-like growth factor-1 receptor deficiency in macrophages accelerates atherosclerosis and induces an unstable plaque phenotype in apolipoprotein E-deficient mice","volume":"133","author":"Higashi","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0235","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1161\/01.ATV.0000099788.31333.DB","article-title":"Insulin-like growth factor-1 receptor activation inhibits oxidized LDL-induced cytochrome C release and apoptosis via the phosphatidylinositol 3 kinase\/Akt signaling pathway","volume":"23","author":"Li","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0240","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1161\/01.CIR.0000058169.21850.CE","article-title":"Decreased reendothelialization and increased neointima formation with endostatin overexpression in a mouse model of arterial injury","volume":"107","author":"Hutter","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0021-9150(92)90273-J","article-title":"Stimulatory effects of insulin and insulin-like growth factor I on migration and tube formation by vascular endothelial cells","volume":"92","author":"Nakao-Hayashi","year":"1992","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0250","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.yjmcc.2017.08.014","article-title":"Nitric oxide and CaMKII: critical steps in the cardiac contractile response to IGF-1 and swim training","volume":"112","author":"Burgos","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0255","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1365-2362.1995.tb01721.x","article-title":"A comparison of the effects of IGF-I and insulin on glucose metabolism, fat metabolism and the cardiovascular system in normal human volunteers","volume":"25","author":"Russell-Jones","year":"1995","journal-title":"Eur. J. Clin. Investig."},{"key":"10.1016\/j.ghir.2019.01.002_bb0260","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/diacare.28.1.120","article-title":"Plasma concentration of IGF-I is independently associated with insulin sensitivity in subjects with different degrees of glucose tolerance","volume":"28","author":"Sesti","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ghir.2019.01.002_bb0265","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.2337\/diabetes.50.5.1110","article-title":"Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity","volume":"50","author":"Yakar","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2019.01.002_bb0270","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.2337\/diabetes.50.7.1539","article-title":"Liver-derived IGF-I is of importance for normal carbohydrate and lipid metabolism","volume":"50","author":"Sjogren","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2019.01.002_bb0275","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1161\/01.CIR.0000027563.44593.CC","article-title":"Low serum insulin-like growth factor I is associated with increased risk of ischemic heart disease: a population-based case-control study","volume":"106","author":"Juul","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0280","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1210\/jc.2003-030967","article-title":"The prospective association of serum insulin-like growth factor I (IGF-I) and IGF-binding protein-1 levels with all cause and cardiovascular disease mortality in older adults: the Rancho Bernardo Study","volume":"89","author":"Laughlin","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0285","doi-asserted-by":"crossref","first-page":"64","DOI":"10.14797\/mdcj-13-2-64","article-title":"Cardiovascular disease in acromegaly","volume":"13","author":"Sharma","year":"2017","journal-title":"Methodist Debakey Cardiovasc. J."},{"key":"10.1016\/j.ghir.2019.01.002_bb0290","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP161637.OR","article-title":"Assessment of diastolic dysfunction, arterial stiffness, and carotid intima-media thickness in patients with acromegaly","volume":"23","author":"Cansu","year":"2017","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ghir.2019.01.002_bb0295","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1530\/ERC-17-0253","article-title":"Acromegaly at diagnosis in 3173 patients from the Liege Acromegaly Survey (LAS) Database","volume":"24","author":"Petrossians","year":"2017","journal-title":"Endocr. Relat. Cancer"},{"key":"10.1016\/j.ghir.2019.01.002_bb0300","doi-asserted-by":"crossref","first-page":"4223","DOI":"10.1210\/jcem.86.9.7813","article-title":"Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency","volume":"86","author":"Elhadd","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0305","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jcem.87.3.8336","article-title":"The cardiovascular risk of adult GH deficiency (GHD) improved after GH replacement and worsened in untreated GHD: a 12-month prospective study","volume":"87","author":"Colao","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0310","first-page":"195","article-title":"Cardiovascular risk factors in adult patients with growth hormone deficiency","volume":"129","author":"Rosen","year":"1993","journal-title":"Acta Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0315","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1046\/j.1365-2265.1997.d01-1749.x","article-title":"Increased cerebrovascular mortality in patients with hypopituitarism","volume":"46","author":"Bulow","year":"1997","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0320","first-page":"1169","article-title":"The effect of hypopituitarism on life expectancy","volume":"81","author":"Bates","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0325","doi-asserted-by":"crossref","first-page":"682","DOI":"10.4158\/EP.12.6.682","article-title":"Cardiovascular risk in patients with growth hormone deficiency: effects of growth hormone substitution","volume":"12","author":"Burger","year":"2006","journal-title":"Endocr. Pract."},{"key":"10.1016\/j.ghir.2019.01.002_bb0330","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1210\/jc.2005-2571","article-title":"Lack of evidence of premature atherosclerosis in untreated severe isolated growth hormone (GH) deficiency due to a GH-releasing hormone receptor mutation","volume":"91","author":"Oliveira","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0335","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0340","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2174\/1871530317666170919121729","article-title":"GH supplementation effects on cardiovascular risk in GH deficient adult patients: a systematic review and meta-analysis","volume":"17","author":"Giagulli","year":"2017","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/j.ghir.2019.01.002_bb0345","doi-asserted-by":"crossref","first-page":"E762","DOI":"10.1152\/ajpendo.00203.2005","article-title":"Effects of long-term treatment with growth hormone-releasing peptide-2 in the GHRH knockout mouse","volume":"289","author":"Alba","year":"2005","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0350","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1210\/en.2009-0283","article-title":"Growth hormone-releasing peptide-2 suppresses vascular oxidative stress in ApoE\u2212\/\u2212 mice but does not reduce atherosclerosis","volume":"150","author":"Titterington","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0355","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.atherosclerosis.2011.05.034","article-title":"Effects of insulin-like growth factor 1 in preventing acute coronary syndromes: the PRIME study","volume":"218","author":"Ruidavets","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0360","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2015.04.032","article-title":"Insulin-like growth factor-1 in early-onset coronary artery disease: Insights into the pathophysiology of atherosclerosis","volume":"202","author":"De Lorenzo","year":"2016","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0365","doi-asserted-by":"crossref","first-page":"5937","DOI":"10.1210\/jc.2004-2088","article-title":"Insulin-like growth factor (IGF) I, -II, and IGF binding protein-3 and risk of ischemic stroke","volume":"90","author":"Johnsen","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0370","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1210\/jc.2006-1631","article-title":"Association of total insulin-like growth factor-I, insulin-like growth factor binding protein-1 (IGFBP-1), and IGFBP-3 levels with incident coronary events and ischemic stroke","volume":"92","author":"Kaplan","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0375","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/STROKEAHA.116.016563","article-title":"Serum Insulin-like growth factor 1 and the risk of ischemic stroke: the framingham study","volume":"48","author":"Saber","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/j.ghir.2019.01.002_bb0380","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/0003319715586499","article-title":"IGF-1 and insulin resistance are major determinants of common carotid artery thickness in morbidly obese young patients","volume":"67","author":"Sirbu","year":"2016","journal-title":"Angiology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0385","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1161\/01.ATV.0000154486.03017.35","article-title":"Circulating insulin-like growth factor-1 and insulin-like growth factor binding protein-3 are associated with early carotid atherosclerosis","volume":"25","author":"Kawachi","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0390","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1365-2265.2011.04010.x","article-title":"Serum insulin-like growth factor I and its binding protein 3 in their relation to intima-media thickness: results of the study of health in Pomerania (SHIP)","volume":"75","author":"Spilcke-Liss","year":"2011","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0395","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.atherosclerosis.2014.08.022","article-title":"Vitamin D modulates the association of circulating insulin-like growth factor-1 with carotid artery intima-media thickness","volume":"236","author":"Ameri","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0400","first-page":"545804","article-title":"Carotid intima media thickness is independently associated with male gender, middle age, and IGF-1 in metabolically healthy obese individuals","volume":"2014","author":"El-Hafez","year":"2014","journal-title":"ISRN Obes."},{"key":"10.1016\/j.ghir.2019.01.002_bb0405","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2011.10.032","article-title":"The expression of IGFs and IGF binding proteins in human carotid atherosclerosis, and the possible role of IGF binding protein-1 in the regulation of smooth muscle cell proliferation","volume":"220","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0410","doi-asserted-by":"crossref","first-page":"2804","DOI":"10.1210\/jc.2013-3746","article-title":"The association between IGF-I\/IGFBP-3 and subclinical end points: epidemiology faces the limits","volume":"99","author":"Muller","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0415","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.exger.2018.02.015","article-title":"Trajectories of plasma IGF-1, IGFBP-3, and their ratio in the Mayo Clinic Study of Aging","volume":"106","author":"Wennberg","year":"2018","journal-title":"Exp. Gerontol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0420","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/gerona\/glx143","article-title":"Trajectories of IGF-I predict mortality in older adults: the cardiovascular health study","volume":"73","author":"Sanders","year":"2018","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ghir.2019.01.002_bb0425","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1177\/2047487316661436","article-title":"Attenuated IGF-1 predicts all-cause and cardiovascular mortality in a Black population: a five-year prospective study","volume":"23","author":"Schutte","year":"2016","journal-title":"Eur. J. Prev. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0430","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1210\/jc.2009-2329","article-title":"A significant decline in IGF-I may predispose young Africans to subsequent cardiometabolic vulnerability","volume":"95","author":"Schutte","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0435","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1210\/jc.2011-1377","article-title":"Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality","volume":"96","author":"Burgers","year":"2011","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0440","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3109\/14017431.2014.891760","article-title":"IGF-I and IGFBP2 in peripheral artery disease: results of a prospective study","volume":"48","author":"Urbonaviciene","year":"2014","journal-title":"Scand. Cardiovasc. J."},{"key":"10.1016\/j.ghir.2019.01.002_bb0445","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1365-2265.2008.03269.x","article-title":"IGF system and peripheral arterial disease: relationship with disease severity and inflammatory status of the affected limb","volume":"69","author":"Brevetti","year":"2008","journal-title":"Clin. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0450","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12079-015-0259-9","article-title":"The role of PAPP-A in the IGF system: location, location, location","volume":"9","author":"Oxvig","year":"2015","journal-title":"J. Cell Commun. Signal."},{"key":"10.1016\/j.ghir.2019.01.002_bb0455","doi-asserted-by":"crossref","first-page":"3032","DOI":"10.1210\/jc.2015-2196","article-title":"IGFBP-4 fragments as markers of cardiovascular mortality in Type 1 diabetes patients with and without nephropathy","volume":"100","author":"Hjortebjerg","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0460","first-page":"1","article-title":"Novel modulators of the growth hormone - insulin-like growth factor axis: pregnancy-associated plasma protein-A2 and stanniocalcin-2","volume":"9","author":"Fujimoto","year":"2017","journal-title":"J. Clin. Res. Pediatr. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0465","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93735","article-title":"Hepatic JAK2 protects against atherosclerosis through circulating IGF-1","volume":"2","author":"Sivasubramaniyam","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.ghir.2019.01.002_bb0470","doi-asserted-by":"crossref","first-page":"4395","DOI":"10.1210\/en.2009-0272","article-title":"Elevated levels of insulin-like growth factor (IGF)-I in serum rescue the severe growth retardation of IGF-I null mice","volume":"150","author":"Wu","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0475","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/s12020-015-0809-1","article-title":"Increased diet-induced fatty streak formation in female mice with deficiency of liver-derived insulin-like growth factor-I","volume":"52","author":"Svensson","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/j.ghir.2019.01.002_bb0480","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1016\/j.febslet.2011.08.029","article-title":"Differential requirement for nitric oxide in IGF-1-induced anti-apoptotic, anti-oxidant and anti-atherosclerotic effects","volume":"585","author":"Sukhanov","year":"2011","journal-title":"FEBS Lett."},{"key":"10.1016\/j.ghir.2019.01.002_bb0485","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/j.ajpath.2010.10.007","article-title":"IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype","volume":"178","author":"von der Thusen","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0490","doi-asserted-by":"crossref","first-page":"H1898","DOI":"10.1152\/ajpheart.01081.2010","article-title":"Low circulating insulin-like growth factor I increases atherosclerosis in ApoE-deficient mice","volume":"300","author":"Shai","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0495","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1126\/science.180.4093.1332","article-title":"Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis","volume":"180","author":"Ross","year":"1973","journal-title":"Science"},{"key":"10.1016\/j.ghir.2019.01.002_bb0500","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1161\/01.RES.58.4.427","article-title":"Replication of smooth muscle cells in vascular disease","volume":"58","author":"Schwartz","year":"1986","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0505","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00041433-199912000-00005","article-title":"Smooth muscle cell phenotypes in atherosclerotic lesions","volume":"10","author":"Shanahan","year":"1999","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0510","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12933-016-0477-3","article-title":"Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR\/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis","volume":"15","author":"Beneit","year":"2016","journal-title":"Cardiovasc. Diabetol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0515","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1165\/rcmb.2015-0388OC","article-title":"Smooth muscle insulin-like growth factor-1 mediates hypoxia-induced pulmonary hypertension in neonatal mice","volume":"55","author":"Sun","year":"2016","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0520","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yexmp.2010.04.002","article-title":"Insulin-like growth factor-1 induces phosphorylation of PI3K-Akt\/PKB to potentiate proliferation of smooth muscle cells in human saphenous vein","volume":"89","author":"Jia","year":"2010","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0525","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1161\/ATVBAHA.110.210831","article-title":"Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe\u2212\/\u2212 mice does not alter atherosclerotic plaque burden but increases features of plaque stability","volume":"30","author":"Shai","year":"2010","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0530","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1210\/endo.142.8.8331","article-title":"Targeted overexpression of IGF-I in smooth muscle cells of transgenic mice enhances neointimal formation through increased proliferation and cell migration after intraarterial injury","volume":"142","author":"Zhu","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0535","doi-asserted-by":"crossref","first-page":"36112","DOI":"10.1074\/jbc.M703914200","article-title":"Rapamycin promotes vascular smooth muscle cell differentiation through insulin receptor substrate-1\/phosphatidylinositol 3-kinase\/Akt2 feedback signaling","volume":"282","author":"Martin","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0540","doi-asserted-by":"crossref","first-page":"28860","DOI":"10.1074\/jbc.273.44.28860","article-title":"Differentiated phenotype of smooth muscle cells depends on signaling pathways through insulin-like growth factors and phosphatidylinositol 3-kinase","volume":"273","author":"Hayashi","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0545","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.devcel.2005.05.017","article-title":"Phenotypic modulation of smooth muscle cells through interaction of Foxo4 and myocardin","volume":"9","author":"Liu","year":"2005","journal-title":"Dev. Cell"},{"key":"10.1016\/j.ghir.2019.01.002_bb0550","doi-asserted-by":"crossref","first-page":"7264","DOI":"10.1074\/jbc.M113.518951","article-title":"Insulin-like growth factor-1 increases synthesis of collagen type I via induction of the mRNA-binding protein LARP6 expression and binding to the 5\u2032 stem-loop of COL1a1 and COL1a2 mRNA","volume":"289","author":"Blackstock","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0555","series-title":"SM22\u03b1 (Smooth Muscle Protein 22-\u03b1) Promoter-Driven IGF1R (Insulin-Like Growth Factor 1 Receptor) Deficiency Promotes Atherosclerosis, Arteriosclerosis, Thrombosis, and Vascular Biology","author":"Sukhanov","year":"2018"},{"key":"10.1016\/j.ghir.2019.01.002_bb0560","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/mt.2015.66","article-title":"Monocyte\/Macrophage-derived IGF-1 Orchestrates Murine Skeletal Muscle Regeneration and Modulates Autocrine Polarization","volume":"23","author":"Tonkin","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ghir.2019.01.002_bb0565","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1038\/mt.2015.97","article-title":"Macrophage-derived IGF-1 is a potent coordinator of myogenesis and inflammation in regenerating muscle","volume":"23","author":"Tidball","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ghir.2019.01.002_bb0570","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1164\/ajrccm.151.5.7537587","article-title":"Enhanced insulin-like growth factor molecules in idiopathic pulmonary fibrosis","volume":"151","author":"Aston","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0575","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1172\/JCI115879","article-title":"Receptor-specific induction of insulin-like growth factor I in human monocytes by advanced glycosylation end product-modified proteins","volume":"90","author":"Kirstein","year":"1992","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ghir.2019.01.002_bb0580","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.4049\/jimmunol.155.4.2123","article-title":"Divergence in macrophage insulin-like growth factor-I (IGF-I) synthesis induced by TNF-alpha and prostaglandin E2","volume":"155","author":"Fournier","year":"1995","journal-title":"J. Immunol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0585","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.bbrc.2010.03.072","article-title":"IGF-1 increases macrophage motility via PKC\/p38-dependent alphavbeta3-integrin inside-out signaling","volume":"394","author":"Furundzija","year":"2010","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ghir.2019.01.002_bb0590","doi-asserted-by":"crossref","first-page":"4611","DOI":"10.1210\/endo.137.11.8895324","article-title":"Direct stimulatory effect of insulin-like growth factor-I on monocyte and macrophage tumor necrosis factor-alpha production","volume":"137","author":"Renier","year":"1996","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0595","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1210\/endo.131.1.1612024","article-title":"Growth hormone and insulin-like growth factor-I increase macrophage uptake and degradation of low density lipoprotein","volume":"131","author":"Hochberg","year":"1992","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0600","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.atherosclerosis.2014.12.024","article-title":"Insulin-like growth factor I reduces lipid oxidation and foam cell formation via downregulation of 12\/15-lipoxygenase","volume":"238","author":"Sukhanov","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0605","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1097\/00000658-200002000-00014","article-title":"Insulinlike growth factor I plus insulinlike growth factor binding protein 3 attenuates the proinflammatory acute phase response in severely burned children","volume":"231","author":"Jeschke","year":"2000","journal-title":"Ann. Surg."},{"key":"10.1016\/j.ghir.2019.01.002_bb0610","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/00003246-200201000-00013","article-title":"Modulation of types I and II acute phase reactants with insulin-like growth factor-1\/binding protein-3 complex in severely burned children","volume":"30","author":"Spies","year":"2002","journal-title":"Crit. Care Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0615","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.cmet.2006.02.010","article-title":"Myeloid lineage cell-restricted insulin resistance protects apolipoproteinE-deficient mice against atherosclerosis","volume":"3","author":"Baumgartl","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0620","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.cmet.2006.02.008","article-title":"Macrophage insulin receptor deficiency increases ER stress-induced apoptosis and necrotic core formation in advanced atherosclerotic lesions","volume":"3","author":"Han","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0625","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.cmet.2011.07.015","article-title":"Insulin resistance, hyperglycemia, and atherosclerosis","volume":"14","author":"Bornfeldt","year":"2011","journal-title":"Cell Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0630","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1000938","article-title":"C R Kahn, J C Bruning, Myeloid cell-restricted insulin receptor deficiency protects against obesity-induced inflammation and systemic insulin resistance","volume":"6","author":"Mauer","year":"2010","journal-title":"PLoS Genet."},{"key":"10.1016\/j.ghir.2019.01.002_bb0635","doi-asserted-by":"crossref","first-page":"32531","DOI":"10.1074\/jbc.M009894200","article-title":"Insulin up-regulates tumor necrosis factor-alpha production in macrophages through an extracellular-regulated kinase-dependent pathway","volume":"276","author":"Iida","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0640","doi-asserted-by":"crossref","first-page":"E938","DOI":"10.1152\/ajpendo.00427.2015","article-title":"Insulin-induced cytokine production in macrophages causes insulin resistance in hepatocytes","volume":"310","author":"Manowsky","year":"2016","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0645","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/labinvest.2012.74","article-title":"Insulin promotes macrophage foam cell formation: potential implications in diabetes-related atherosclerosis","volume":"92","author":"Park","year":"2012","journal-title":"Lab. Invest."},{"key":"10.1016\/j.ghir.2019.01.002_bb0650","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JME-14-0215","article-title":"Endothelial cells and the IGF system","volume":"54","author":"Bach","year":"2015","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0655","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000360571","article-title":"Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging","volume":"43","author":"Higashi","year":"2014","journal-title":"Front. Horm. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0660","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.116.004910","article-title":"Increased vascular permeability measured with an albumin-binding magnetic resonance contrast agent is a surrogate marker of rupture-prone atherosclerotic plaque","volume":"9","author":"Phinikaridou","year":"2016","journal-title":"Circ. Cardiovasc. Imaging"},{"key":"10.1016\/j.ghir.2019.01.002_bb0665","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/en.2015-1840","article-title":"Insulin-like growth factor (IGF)-I modulates endothelial blood-brain barrier function in ischemic middle-aged female rats","volume":"157","author":"Bake","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0670","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.ajpath.2015.01.027","article-title":"Protective role of insulin-like growth factor-1 receptor in endothelial cells against unilateral ureteral obstruction-induced renal fibrosis","volume":"185","author":"Liang","year":"2015","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0675","doi-asserted-by":"crossref","first-page":"22961","DOI":"10.1074\/jbc.M109.014787","article-title":"Increased intraocular insulin-like growth factor-I triggers blood-retinal barrier breakdown","volume":"284","author":"Haurigot","year":"2009","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0680","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/j.bbadis.2011.04.007","article-title":"GSK-3beta\/CREB axis mediates IGF-1-induced ECM\/adhesion molecule expression, cell cycle progression and monolayer permeability in retinal capillary endothelial cells: Implications for diabetic retinopathy","volume":"1812","author":"Devi","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ghir.2019.01.002_bb0685","first-page":"32","article-title":"Effects of VEGFR-1, VEGFR-2, and IGF-IR hammerhead ribozymes on glucose-mediated tight junction expression in cultured human retinal endothelial cells","volume":"12","author":"Spoerri","year":"2006","journal-title":"Mol. Vis."},{"key":"10.1016\/j.ghir.2019.01.002_bb0690","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s00125-011-2416-x","article-title":"Disruption of the association of integrin-associated protein (IAP) with tyrosine phosphatase non-receptor type substrate-1 (SHPS)-1 inhibits pathophysiological changes in retinal endothelial function in a rat model of diabetes","volume":"55","author":"Maile","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/j.ghir.2019.01.002_bb0695","doi-asserted-by":"crossref","first-page":"III27","DOI":"10.1161\/01.CIR.0000131515.03336.f8","article-title":"Role of endothelial dysfunction in atherosclerosis","volume":"109","author":"Davignon","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0700","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1161\/01.CIR.84.5.1984","article-title":"Endothelial dysfunction of the coronary microvasculature is associated with coronary blood flow regulation in patients with early atherosclerosis","volume":"84","author":"Zeiher","year":"1991","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0705","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1074\/jbc.M114.603142","article-title":"Specific activation of insulin-like growth factor-1 receptor by ginsenoside Rg5 promotes angiogenesis and vasorelaxation","volume":"290","author":"Cho","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0710","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/ki.1994.78","article-title":"Direct demonstration of insulin-like growth factor-I-induced nitric oxide production by endothelial cells","volume":"45","author":"Tsukahara","year":"1994","journal-title":"Kidney Int."},{"key":"10.1016\/j.ghir.2019.01.002_bb0715","doi-asserted-by":"crossref","first-page":"2806","DOI":"10.1210\/jc.2008-0646","article-title":"Low-plasma insulin-like growth factor-I levels are associated with impaired endothelium-dependent vasodilatation in a cohort of untreated, hypertensive Caucasian subjects","volume":"93","author":"Perticone","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0720","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.2337\/db11-0197","article-title":"The insulin-like growth factor-1 receptor is a negative regulator of nitric oxide bioavailability and insulin sensitivity in the endothelium","volume":"60","author":"Abbas","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2019.01.002_bb0725","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/db11-1494","article-title":"Novel role of the IGF-1 receptor in endothelial function and repair: studies in endothelium-targeted IGF-1 receptor transgenic mice","volume":"61","author":"Imrie","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.ghir.2019.01.002_bb0730","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/CIRCRESAHA.116.309678","article-title":"Selective enhancement of insulin sensitivity in the endothelium in vivo reveals a novel proatherosclerotic signaling loop","volume":"120","author":"Viswambharan","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0735","doi-asserted-by":"crossref","first-page":"6349","DOI":"10.1074\/jbc.M114.634154","article-title":"Insulin-like growth factor 1 (IGF-1) stabilizes nascent blood vessels","volume":"290","author":"Jacobo","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0740","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jacc.2007.12.025","article-title":"Hypoxia, hypoxia-inducible transcription factor, and macrophages in human atherosclerotic plaques are correlated with intraplaque angiogenesis","volume":"51","author":"Sluimer","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0745","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1161\/01.ATV.0000178991.71605.18","article-title":"Atherosclerotic plaque progression and vulnerability to rupture: angiogenesis as a source of intraplaque hemorrhage","volume":"25","author":"Virmani","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0750","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.redox.2017.01.007","article-title":"Angiogenesis in the atherosclerotic plaque","volume":"12","author":"Camare","year":"2017","journal-title":"Redox Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0755","doi-asserted-by":"crossref","first-page":"3017","DOI":"10.1161\/01.CIR.0000018166.84319.55","article-title":"Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells","volume":"105","author":"Walter","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0760","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/CIRCULATIONAHA.107.746008","article-title":"Rapid endothelial turnover in atherosclerosis-prone areas coincides with stem cell repair in apolipoprotein E-deficient mice","volume":"117","author":"Foteinos","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0765","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/01.RES.0000257912.78915.af","article-title":"Age-dependent impairment of endothelial progenitor cells is corrected by growth-hormone-mediated increase of insulin-like growth-factor-1","volume":"100","author":"Thum","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0770","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1210\/jc.2007-0922","article-title":"Growth hormone treatment improves markers of systemic nitric oxide bioavailability via insulin-like growth factor-I","volume":"92","author":"Thum","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0775","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/EJE-08-0179","article-title":"Recombinant human GH replacement increases CD34+ cells and improves endothelial function in adults with GH deficiency","volume":"159","author":"van der Klaauw","year":"2008","journal-title":"Eur. J. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0780","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1538-7836.2009.03607.x","article-title":"Insulin-like growth factor-1 protects from vascular stenosis and accelerates re-endothelialization in a rat model of carotid artery injury","volume":"7","author":"Cittadini","year":"2009","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ghir.2019.01.002_bb0785","first-page":"825","article-title":"Circulating endothelial progenitor cells in acromegaly","volume":"36","author":"Bellastella","year":"2013","journal-title":"J. Endocrinol. Investig."},{"key":"10.1016\/j.ghir.2019.01.002_bb0790","doi-asserted-by":"crossref","first-page":"E2549","DOI":"10.1210\/jc.2014-2275","article-title":"Endothelial progenitor cells are reduced in acromegalic patients and can be restored by treatment with somatostatin analogs","volume":"99","author":"Fadini","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0795","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/gerona\/glr164","article-title":"Liver-specific knockdown of IGF-1 decreases vascular oxidative stress resistance by impairing the Nrf2-dependent antioxidant response: a novel model of vascular aging","volume":"67","author":"Bailey-Downs","year":"2012","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.ghir.2019.01.002_bb0800","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bbadis.2012.12.005","article-title":"Insulin-like growth factor-1 regulates glutathione peroxidase expression and activity in vascular endothelial cells: Implications for atheroprotective actions of insulin-like growth factor-1","volume":"1832","author":"Higashi","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.ghir.2019.01.002_bb0805","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.jacc.2017.05.035","article-title":"Impact of oxidative stress on the heart and vasculature: part 2 of a 3-part series","volume":"70","author":"Munzel","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0810","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.jacc.2017.05.034","article-title":"Basic biology of oxidative stress and the cardiovascular system: part 1 of a 3-part series","volume":"70","author":"Sack","year":"2017","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0815","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fendo.2018.00134","article-title":"Insulin-like growth factor binding proteins and IGFBP proteases: a dynamic system regulating the ovarian folliculogenesis","volume":"9","author":"Mazerbourg","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"key":"10.1016\/j.ghir.2019.01.002_bb0820","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.tem.2012.02.008","article-title":"Key questions and answers about pregnancy-associated plasma protein-a","volume":"23","author":"Conover","year":"2012","journal-title":"Trends Endocrinol. Metab."},{"key":"10.1016\/j.ghir.2019.01.002_bb0825","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1056\/NEJMoa003147","article-title":"Pregnancy-associated plasma protein A as a marker of acute coronary syndromes","volume":"345","author":"Bayes-Genis","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0830","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.1161\/01.ATV.0000047448.76485.B8","article-title":"Serum plasma pregnancy-associated protein a: a potential marker of echogenic carotid atherosclerotic plaques in asymptomatic hyperlipidemic subjects at high cardiovascular risk","volume":"23","author":"Beaudeux","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0835","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1161\/01.CIR.0000096054.18485.07","article-title":"Circulating pregnancy-associated plasma protein a predicts outcome in patients with acute coronary syndrome but no troponin I elevation","volume":"108","author":"Lund","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ghir.2019.01.002_bb0840","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jacc.2012.04.023","article-title":"Prospective evaluation of pregnancy-associated plasma protein-a and outcomes in patients with acute coronary syndromes","volume":"60","author":"Bonaca","year":"2012","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0845","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.1016\/j.jacc.2005.07.033","article-title":"Pregnancy-associated plasma protein-A and acute coronary syndromes: cause or consequence?","volume":"46","author":"Conti","year":"2005","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0850","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.clinbiochem.2010.12.010","article-title":"Pregnancy associated plasma protein-a (PAPP-A) is not a marker of the vulnerable atherosclerotic plaque","volume":"44","author":"Iversen","year":"2011","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0855","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1210\/en.2013-1320","article-title":"Inducible knock out of pregnancy-associated plasma protein-a gene expression in the adult mouse: effect on vascular injury response","volume":"154","author":"Conover","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0860","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/CIRCRESAHA.106.146183","article-title":"Genetic deletion of pregnancy-associated plasma protein-a is associated with resistance to atherosclerotic lesion development in apolipoprotein E-deficient mice challenged with a high-fat diet","volume":"100","author":"Harrington","year":"2007","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0865","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.00904.2009","article-title":"Transgenic overexpression of pregnancy-associated plasma protein-a in murine arterial smooth muscle accelerates atherosclerotic lesion development","volume":"299","author":"Conover","year":"2010","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0870","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/en.2013-2110","article-title":"Inducible reduction in pregnancy-associated plasma protein-A gene expression inhibits established atherosclerotic plaque progression in mice","volume":"155","author":"Bale","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0875","doi-asserted-by":"crossref","first-page":"9765","DOI":"10.1007\/s11357-015-9765-1","article-title":"Female PAPP-A knockout mice are resistant to metabolic dysfunction induced by high-fat\/high-sucrose feeding at middle age","volume":"37","author":"Hill","year":"2015","journal-title":"Age (Dordr.)"},{"key":"10.1016\/j.ghir.2019.01.002_bb0880","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1210\/en.2012-1552","article-title":"Effects of mutated pregnancy-associated plasma protein-a on atherosclerotic lesion development in mice","volume":"154","author":"Boldt","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/j.ghir.2019.01.002_bb0885","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1677\/joe.0.1750019","article-title":"IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms","volume":"175","author":"Mohan","year":"2002","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0890","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1593\/neo.13212","article-title":"IGFBP-4 anti-angiogenic and anti-tumorigenic effects are associated with anti-cathepsin B activity","volume":"15","author":"Moreno","year":"2013","journal-title":"Neoplasia"},{"key":"10.1016\/j.ghir.2019.01.002_bb0895","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12265-015-9666-9","article-title":"Targeted inhibition of pregnancy-associated plasma protein-a activity reduces atherosclerotic plaque burden in mice","volume":"9","author":"Conover","year":"2016","journal-title":"J. Cardiovasc. Transl. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0900","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.atherosclerosis.2016.02.026","article-title":"Stanniocalcin-2 overexpression reduces atherosclerosis in hypercholesterolemic mice","volume":"248","author":"Steffensen","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0905","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1210\/me.2011-0035","article-title":"IGF-I stimulates cooperative interaction between the IGF-I receptor and CSK homologous kinase that regulates SHPS-1 phosphorylation in vascular smooth muscle cells","volume":"25","author":"Radhakrishnan","year":"2011","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0910","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1074\/jbc.M116.758987","article-title":"Down-regulation of insulin receptor substrate 1 during hyperglycemia induces vascular smooth muscle cell dedifferentiation","volume":"292","author":"Xi","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ghir.2019.01.002_bb0915","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ghir.2007.01.004","article-title":"Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress","volume":"17","author":"Clemmons","year":"2007","journal-title":"Growth Hormon. IGF Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0920","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3000476","article-title":"A monoclonal antibody against alphaVbeta3 integrin inhibits development of atherosclerotic lesions in diabetic pigs","volume":"2","author":"Maile","year":"2010","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ghir.2019.01.002_bb0925","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.1096\/fj.15-275453","article-title":"Hyperglycemia stimulates p62\/PKCzeta interaction, which mediates NF-kappaB activation, increased Nox4 expression, and inflammatory cytokine activation in vascular smooth muscle","volume":"29","author":"Xi","year":"2015","journal-title":"FASEB J."},{"key":"10.1016\/j.ghir.2019.01.002_bb0930","doi-asserted-by":"crossref","first-page":"39740","DOI":"10.18632\/oncotarget.9240","article-title":"Down-regulation of microRNA-320 suppresses cardiomyocyte apoptosis and protects against myocardial ischemia and reperfusion injury by targeting IGF-1","volume":"7","author":"Song","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.ghir.2019.01.002_bb0935","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1038\/nature06607","article-title":"Regulation of progenitor cell proliferation and granulocyte function by microRNA-223","volume":"451","author":"Johnnidis","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.ghir.2019.01.002_bb0940","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/cvr\/cvw065","article-title":"I Fleming, miR-223-IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach","volume":"111","author":"Shi","year":"2016","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0945","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/CIRCRESAHA.113.302400","article-title":"Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c","volume":"113","author":"Abonnenc","year":"2013","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0950","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.atherosclerosis.2013.11.029","article-title":"MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis","volume":"232","author":"Gao","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ghir.2019.01.002_bb0955","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1093\/cvr\/cvt172","article-title":"MiR-490-3p modulates the proliferation of vascular smooth muscle cells induced by ox-LDL through targeting PAPP-A","volume":"100","author":"Sun","year":"2013","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0960","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/nrm.2017.125","article-title":"Shedding light on the cell biology of extracellular vesicles","volume":"19","author":"van Niel","year":"2018","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0965","doi-asserted-by":"crossref","first-page":"8180","DOI":"10.1038\/s41598-017-08250-0","article-title":"Serum-derived extracellular vesicles (EVs) impact on vascular remodeling and prevent muscle damage in acute hind limb ischemia","volume":"7","author":"Cavallari","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ghir.2019.01.002_bb0970","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ijcard.2014.10.144","article-title":"Repeated remote ischemic conditioning attenuates left ventricular remodeling via exosome-mediated intercellular communication on chronic heart failure after myocardial infarction","volume":"178","author":"Yamaguchi","year":"2015","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0975","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1093\/cvr\/cvy055","article-title":"Cardioprotection by cardiac progenitor cell-secreted exosomes: role of pregnancy-associated plasma protein-A","volume":"114","author":"Barile","year":"2018","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb0980","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.yjmcc.2014.05.001","article-title":"Cardiomyocytes mediate anti-angiogenesis in type 2 diabetic rats through the exosomal transfer of miR-320 into endothelial cells","volume":"74","author":"Wang","year":"2014","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0985","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4049\/jimmunol.1301790","article-title":"Platelet-secreted microRNA-223 promotes endothelial cell apoptosis induced by advanced glycation end products via targeting the insulin-like growth factor 1 receptor","volume":"192","author":"Pan","year":"2014","journal-title":"J. Immunol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0990","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/s00395-017-0628-z","article-title":"Exercise-induced circulating extracellular vesicles protect against cardiac ischemia-reperfusion injury","volume":"112","author":"Bei","year":"2017","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ghir.2019.01.002_bb0995","doi-asserted-by":"crossref","first-page":"e53","DOI":"10.1161\/RES.0000000000000169","article-title":"Recommendation on design, execution, and reporting of animal atherosclerosis studies: a scientific statement from the American Heart Association","volume":"121","author":"Daugherty","year":"2017","journal-title":"Circ. Res."},{"key":"10.1016\/j.ghir.2019.01.002_bb1000","first-page":"253","article-title":"Atherosclerosis in relation to the structure and function of the arterial intima, with special reference to th endothelium","volume":"5","author":"French","year":"1966","journal-title":"Int. Rev. Exp. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb1005","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0014-4800(82)90054-5","article-title":"Pathogenesis of diffuse intimal thickening (DIT) in aortas and coronary arteries of 2 1\/2-year-old miniature pigs","volume":"37","author":"Stout","year":"1982","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.ghir.2019.01.002_bb1010","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1161\/01.RES.77.3.445","article-title":"The intima. Soil for atherosclerosis and restenosis","volume":"77","author":"Schwartz","year":"1995","journal-title":"Circ. Res."}],"container-title":["Growth Hormone &amp; IGF Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637419300097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1096637419300097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T22:51:00Z","timestamp":1761087060000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1096637419300097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":202,"alternative-id":["S1096637419300097"],"URL":"https:\/\/doi.org\/10.1016\/j.ghir.2019.01.002","relation":{},"ISSN":["1096-6374"],"issn-type":[{"value":"1096-6374","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IGF-1 and cardiovascular disease","name":"articletitle","label":"Article Title"},{"value":"Growth Hormone & IGF Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ghir.2019.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}